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Mitochondrial cytochrome c oxidase (CcO) or respiratory chain complex IV is a heme aa3copper oxygen reductase containing metal centers essential for holo-complex biogenesis and
enzymatic function that are assembled by subunit-speciﬁc metallochaperones. The enzyme
has two copper sites located in the catalytic core subunits. The COX1 subunit harbors the CuB
site that tightly associates with heme a3 while the COX2 subunit contains the binuclear CuA
site. Here, we report that in human cells the CcO copper chaperones form macromolecular
assemblies and cooperate with several twin CX9C proteins to control heme a biosynthesis
and coordinate copper transfer sequentially to the CuA and CuB sites. These data on CcO
illustrate a mechanism that regulates the biogenesis of macromolecular enzymatic assemblies with several catalytic metal redox centers and prevents the accumulation of cytotoxic
reactive assembly intermediates.
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erobic life relies on electron transport reactions that
facilitate fundamental processes such as cellular
respiration1. These biological electron transfer reactions
are performed predominantly by proteins and rely on the presence of critical redox cofactors such as heme a and copper (Cu),
the prosthetic groups of cytochrome c oxidase (CcO)2. However,
for enzymatic complexes with multiple redox cofactors, uncoordinated or dysregulated biogenesis of the redox centers may result
in the overproduction of reactive intermediates leading to progressive loss of cellular function and eventual death3,4. Therefore,
cells must develop safety mechanisms to coordinate the biogenesis of multimeric enzymes that contain multiple redox centers.
In most systems, such as mammalian CcO, these mechanisms
remain incompletely characterized.
CcO is the terminal complex of the electron transport chain
(ETC), required for aerobic adenosine 5’-triphosphate (ATP)
production from aerobic bacteria to mammals2. Mammalian CcO
or mitochondrial ETC complex IV (CIV) is formed by three
conserved catalytic core transmembrane subunits (COX1, COX2,
and COX3) encoded by the mitochondrial genome (mtDNA) and
eleven nucleus-encoded accessory subunits2. CcO has two copper
(Cu)-centers: CuA in COX2 and CuB in COX1. The CuA site
includes two Cu atoms of mixed valence and localizes to a
hydrophilic COX2 domain in the intermembrane space (IMS).
The CuB site contains a single Cu ion that coordinates with a
high-spin heme a3 and a cross-linked His-Tyr cofactor to form
the O2 reduction, or ‘active’, site5. Near the active site, COX1 also
harbors a low-spin heme a. During catalysis, electrons transfer
from reduced cytochrome c to the CuA center in COX2. The
electrons then ﬂow from the CuA site to heme a in COX1 and are
transferred to the CuB-heme a3 center, which binds and reduces
O2 to H2O 2. The process is coupled to proton ﬂow across the
inner membrane to contribute to the proton gradient required for
ATP synthesis by oxidative phosphorylation6. CcO deﬁciency is
among the most recurrent causes of human mitochondrial disorders, frequently owing to mutations that impair CcO biogenesis
and cause devastating cardio- and encephalomyopathies7,8.
Mitochondrial CcO biogenesis is a modular process hypothesized to involve the independent maturation of COX1 and COX2
followed by sequential interactions with accessory subunits and
assembly factors. The overall process requires over 30 nucleusencoded assembly factors (Supplementary Table 1)2, ﬁve of which
are required to assemble the four-subunit aa3-type CcO of αproteobacteria, such as Rhodobacter sphaeroides. They function to
synthesize (COX10 and COX15) or deliver (SURF) heme a, and
assemble CuA (SCO) or CuB (COX11) sites2,9. In mitochondria,
heme a and Cu insertion into COX1 and COX2 is essential for
modular assembly2. In the current model, the soluble IMS Cuchaperone COX17, which has a twin CX9C structural motif and a
CHCH Cu(I) binding motif, transfers Cu(I) to the IMS-exposed
Cu-binding domains of IM-anchored COX11 and two SCO
proteins (SCO1 and SCO2). COX11 and SCO1/SCO2 speciﬁcally
and directly transfer Cu to the CuB and CuA sites, respectively.
The human CuA assembly mechanism is relatively well understood. It occurs in a module that contains the COX2
folding chaperone COX20, SCO1 for Cu transfer, SCO2 in
Cu binding and disulﬁde reduction, and the IMS twin CX9C
protein COA6 cooperating as a copper chaperone or a thiol
oxidoreductase2,10–15. Formation of the CuB site in COX1 is less
understood. The requirement of COX11 is only supported by
studies in bacteria and yeast9,16,17 and is assumed to occur
similarly in human mitochondria. In yeast, COX11 activity is
essential for CuB assembly and depends on the twin CX9C protein
COX19, which prevents COX11 overoxidation18. Newly synthesized human COX1 associates with its folding chaperones COA3
and COX14 and another IMS twin CX9C protein, CMC119. Cu
2

insertion into COX1 was proposed to occur in this module, but
interaction with human COX11 or COX19 has not been
demonstrated.
Despite the wealth of biochemical and structural information
available on human CcO biogenesis, the process of CuB site
assembly lacks understanding. Whether mechanisms are in place
to couple heme a biosynthesis and CuB assembly, synchronize Cu
delivery to CuB and CuA, and coordinate the merging of the
COX1 and COX2 assembly modules remains unknown. Herein,
we set out to unravel these mechanisms by characterizing human
cell lines lacking COX11 and COX19 physiologically and biochemically. We conclude that dynamic metallochaperone modules involving heme a biosynthetic enzymes, COX1- and COX2speciﬁc copper chaperones, which are regulated by several twin
CX9C proteins, including COX17, COX19, PET191, and COA6,
coordinate the assembly of catalytic metal redox centers in
human CcO. The regulatory mechanism is fundamental for CcO
assembly and prevents the accumulation of heme-containing CcO
assembly intermediates lacking copper, which induce oxidativestress mediated cytotoxicity.
Results
COX19 is essential for human CcO biogenesis, but the absence
of COX11 allows some residual CcO assembly and function.
We used the CRISPR-Cas9 technology to create stable human
HEK293T cell line KOs for COX11, or COX19 (Supplementary
Fig. 1A–D, G). Compared to wild-type (WT), the COX11-KO line
retained 50% of COX1 and 15% of COX2 steady-state levels and
15% of residual fully assembled CcO (labeled as CIV in the BNPAGE assays) (Fig. 1A–C) and CcO activity (Fig. 1D), which
supported 60% of respiratory capacity (Fig. 1E). By contrast, the
COX1 levels in the COX19-KO line were 25% of WT, and COX2
was undetectable, resulting in the loss of holo-CIV, CcO activity,
and cellular respiration (Fig. 1B, E and Supplementary Fig. 2A, C,
D, G). The two cell lines accrue COX1-containing CIV subassemblies (Fig. 1C and Supplementary Fig. 2C, D), reﬂecting an
early CcO assembly defect. These CIV assembly intermediates
(labeled as S1-S4) contain COX1 but not COX2 (Fig. 1B and
Supplementary Fig. 2C, D), and are similar to the intermediates
that accumulate in cell lines carrying mutations that prevent
COX2 incorporation (SURF120–23) or metalation (SCO120,23).
The COX11-KO total mitochondrial cytochrome spectra showed
an α peak corresponding to hemes a + a3 of ~75% of WT
(Fig. 1F), markedly higher than expected for the residual CcO
activity in this line.
Approximately 15% of hemes a + a3, compared to WT, was
detected in the COX19-KO line despite lacking CcO. In both
mutants, the spectra revealed a 5–6 nm blue shift in the α peak
(597 nm versus 603 nm for WT) (Fig. 1F) indicating alterations in
the environments surrounding the heme centers in COX1, as
observed in cox11Δ R. sphaeroides strains9. It also implies that
heme a biosynthesis and delivery to COX1 can proceed
independently of COX11 and COX19. All the phenotypes in
the KO lines were restored to WT levels by reconstitution with
the corresponding FLAG-tagged WT proteins (Fig. 1A, C and
Supplementary Fig. 2A, C), which excluded CRISPR off-target
effects. Whereas COX19 is essential for human CcO biogenesis,
the absence of COX11 allows some residual CcO assembly—
suggesting a potential alternative pathway for CuB metalation in
metazoans. This was unexpected given the essentiality of yeast
Cox11 for CcO assembly. Heterologous complementation studies
showed that the yeast and human COX11 proteins are not
interchangeable, despite being stable in the heterologous
mitochondrial compartments (Supplementary Fig. 3A–C).
Culture media supplementation with CuCl2, His-Cu(II), or
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elesclomol-Cu(II), known to alleviate the CcO deﬁciency in SCO2
patient cell lines and a coa6Δ yeast mutant24,25, did not enhance
CcO activity in COX11-KO cells (Fig. 1G, H, J). Thus, CuB cannot
self-assemble, and high Cu concentrations do not drive an
alternative Cu-chaperone to substitute for COX11.
Overexpression of PET191 partially mitigates the CcO deﬁciency of COX11-KO cells. COX19 contains four structural
cysteine residues in two disulﬁdes but lacks any Cu-binding
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motif. It does not play any overlapping role with COX11, as
overexpression of COX19 in the COX11-KO cell line did not
improve its residual CcO activity or vice versa. (Fig. 1D and
Supplementary Fig. 2G). Also, although SCO proteins have been
implicated in the assembly of CuB in α-proteobacteria with cbb3type oxidases17, SCO1 or SCO2 overexpression did not restore
CcO activity in COX11-KO cells even in the presence of exogenous Cu (Fig. 1D, H, I). Neither COA6 nor COX17 had a
suppressive effect in COX11-KO cells (Fig. 1D, H). By contrast,
our screen identiﬁed another IMS-resident twin CX9C protein,
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Fig. 1 COX11 is dispensable for CcO biogenesis in human mitochondria. A Steady-state levels of CcO subunits and assembly factors in COX11-KO cells.
B Heat map showing the levels of CcO subunits and assembly factors normalized by ACTIN levels in COX11-KO, COX19-KO, and PET191-KO cells, presented
as % of WT The map represents the average of three independent experiments. Two-sided unpaired t-test, *p < 0.05. C BN-PAGE analysis of ETC
complexes (CIII2, CIV, CIV2) and supercomplexes (III2 + CIV and I + III2 + CIVn) in COX11-KO cells reconstituted or not with WT COX11. CIV
subassemblies (sub CIV) are labeled as S1-S3. S1 contains COX1-COX14-COA3-CMC1 and S2-S3 contain COX1-COX14-COA3-COX4-COX5a with or
without assembly factors such as SURF1 or MITRAC719. S4 is a CIV subcomplex formed by the off-pathway joining of the COX1 and COX3 assembly
modules when COX2 is absent or in limited amounts76. D, G–J CIV (CcO) activity measured spectrophotometrically in the indicated cell lines. In
G, H, J, the cells were incubated in the presence or absence of 1 mM CuCl2 or 1 nM elesclomol (ES) + 1 mM CuCl2 for 7 days. The bar graphs represent the
average ± SD of three independent experiments. Black dots represent individual data points. Two-sided unpaired t-test, ****p < 0.0001. E Endogenous cell
respiration measured polarographically in COX11-KO, COX19-KO, or PET191-KO cells reconstituted or not with the corresponding WT gene. The bar graphs
represent the average ± SD of three independent experiments. Black dots represent individual data points. Two-sided unpaired t-test, ****p < 0.0001.
F Total mitochondrial cytochrome spectra. Cytochromes c and c1 peak at 550 nm and cytochrome b peaks at 560 nm. The precise wavelength at which the
absorbance of a + a3 cytochromes peak is annotated. The height of the peaks was calculated using the Quant mode of the UV-Probe software (Shimadzu)
and expressed as the a + a3/b ratio. In the lower graph, the data from three independent experiments were plotted with bars representing the mean ± SD.
Black dots represent individual data points. Two-sided unpaired t-test. G–J CcO activity measured spectrophotometrically in the indicated cell lines. In
G, J, the cells were incubated in the presence or absence of 1.5 mM Cu-His for 7–10 days with addition or not of elesclomol (ES) as indicated in G. The bar
graphs represent the average ± SD of three independent experiments. Black dots represent individual data points. Two-sided unpaired t-test,
****p < 0.0001. ns, no signiﬁcant. K Steady-state levels of CcO subunits and assembly factors in COX11-KO cells overexpressing CcO assembly factors. The
bar graphs represent the average ± SD of three independent experiments. Black dots represent individual data points. Two-sided unpaired t-test,
****p < 0.0001. ns, no signiﬁcant. Figures A, C, K are representative of three independent repetitions with similar results. Source data for A, B, and D–K, are
provided as a Source Data ﬁle.

PET191 (alias COA5), whose overexpression enhanced CcO
levels and activity in COX11-KO cells from 15% to 40% of WT,
and up to 50% when co-overexpressed with COX17 (Fig. 1D, I, J).
Additional overexpression of SCO1/ SCO2 (Fig. 1I) or exogenous
Cu (Fig. 1J) had no additive effect on CcO activity. In addition to
enhancing CcO activity, PET191 overexpression also elevated the
steady-state levels of CcO catalytic subunits COX1 and COX2
(Fig. 1K), albeit the native CcO enzyme levels were only increased
in the supercomplex structures (Supplementary Fig. 4F–G).
PET191 overexpression slightly, yet signiﬁcantly, modiﬁed the
a + a3 cytochrome spectra (Fig. 1F and Source Data), with a
fraction of the α peak red-shifted (~600 nm vs. 597 nm in COX11KO) (Fig. 1F), suggesting that the binuclear center may be in or
closer to its native state in this fraction.
PET191 is essential for CcO assembly in yeast26 and weakly
suppresses the growth defect on synthetic medium containing
galactose of a cox11Δ strain (Supplementary Fig. 5A–C). Human
PET191 mutations lead to CcO deﬁciency and fatal hypertrophic
cardiomyopathy27. We used transcription activator-like effector
nucleases (TALENs) to generate HEK293T PET191-KO cell lines
(Supplementary Fig. 1E–G), which had a phenotype akin to
COX19-KO cells, with undetectable levels of COX2 and holo-CIV
(Supplementary Fig. 2B, E). Thus, PET191 is essential for CcO
biogenesis in human cells. PET191 has four structural cysteines
forming two disulﬁdes and two additional cysteines (C30 and
C41), one of which is functionally essential in yeast26. Reconstitution of PET191-KO cells with WT PET191 restored all the
phenotypes while the mutant PET191(C30A, C41A) partially
restored CcO activity (Supplementary Fig. 4A–C). The extra
cysteines in PET191 could play a role in Cu or redox transfer since
their mutation abolished PET191 capacity to suppress the COX11KO CcO deﬁciency (Fig. 1D and Supplementary Fig. 4E–G).
COX19, PET191, COA6, and COX2 are essential to maintain
the redox state and copper-binding capacity of COX11.
Anchored in the inner membrane by a single transmembrane
domain, mitochondrial COX11 has a C-terminal soluble headgroup located in the IMS. The headgroup has a β-sheet immunoglobulin-like fold that contains the C217 and C219 residues in
the human CcO, forming the conserved copper-binding CFCF
motif28 (Fig. 2A). A third cysteine residue, C121 in human CcO,
locates immediately above the IMS surface of the membrane and
4

participates in copper transfer to COX116,17,29. Functional bacterial COX11 is a dimer28, with 2Cu(I) −4Cys centers facing the
membrane and oriented to be near one of the two C121 residues
while also interacting with two of the three COX1 histidine
ligands of CuB, enabling Cu transfer17.
We used an IAA/AMS-based reverse thiol-trapping approach
to assess the native redox state of human COX11. Native COX11
can potentially be in three combinations of conformations and
redox states: (i) Dimeric Cu-bound COX11. Stable copper binding
to COX11 is absolutely dependent upon dimerization17. Cubound dimeric COX11 (Cu(I)·COX11) has two cysteines, C217
and C219, engaged in Cu coordination, and a reduced cysteine,
C121, per monomer, which in the reverse thiol-trapping assay
would result in the addition of 2 AMS molecules -to C217 and
C219 (Fig. 2A). (ii) Oxidized apo-COX11. Although an intramolecular disulﬁde between C217 and C219 has not been observed
in bacteria17, it has been suggested in yeast18. In such a case, each
monomer would bind 2 AMS molecules in the thiol-trapping
assay (Fig. 2A). (iii) Reduced apo-COX11. In our assay, this
scenario would result in no AMS binding (Fig. 2A).
Our reverse thiol-trapping analyses showed that in WT
HEK293T cells, 50% of COX11 is Cu(I)·COX11 or oxidized
monomeric COX11 (2AMS bound), but in COX19-KO and
PET191-KO cells, COX11 is fully reduced in the apo-state (0
AMS bound) (Fig. 2B). The fraction of 2AMS-bound COX11 in
COX16-KO was slightly increased compared to WT (Fig. 2C). By
contrast, only apo-COX11 was detected in COA6-KO, which links
COX11 to proteins, such as COA6, involved in COX2 metalation.
We then assessed the COX11 redox state in WT 143B cells, in
which more than 80% is Cu(I)·COX11, and homoplasmic cybrid
cell lines lacking COX1, COX2, or COX3. The proportion of
Cu(I)·COX11 + oxidized COX11 in COX3 cybrids was similar to
WT, 50% in COX1 cybrids, and ~5% in COX2 cybrids (Fig. 2D).
These data functionally link COX11—as well as COX19 and
PET191—to COX2 biogenesis.
To further analyze the dimerization state of COX11, we
expressed functional COX11-FLAG in cell lines KO for COX19,
COX16 or COA6, which also contain endogenous COX11, and
performed FLAG-immunoprecipitation (IP) assays. In the absence
of either COX16 or COA6, a fraction of endogenous COX11 was
co-immunoprecipitated (Supplementary Fig. 6A, B), indicating
that human COX11 dimer formation is not strictly dependent of
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Fig. 2 COX11 redox state and copper binding are regulated by PET191 and COX19. A Reverse thiol trapping approach to detect the native cysteine
residues inaccessible to a cell-permeable alkylating compound (2-iodoacetamide, IAA) that upon denaturation with SDS (sodium dodecyl sulfate) and full
reduction with TCEP (tris(2-carboxyethyl)phosphine) are bound to AMS (4-acetamido-4’-maleimidylstilbene-2,2’- disulfonic acid), which adds ~540 Da
per thiol. Three potential scenarios are depicted to account for copper (Cu)-bound COX11 dimer and oxidized or reduced COX11 monomers. B–D Reverse
COX11 thiol trapping in the indicated cell lines. The bar graphs represent the average ± SD of four independent experiments. Two-sided unpaired t-test,
****p < 0.0001. Figures B–D are representative of three independent repetitions with similar results. Source data for B–D are provided as a Source Data ﬁle.
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its redox and copper-binding states. No endogenous COX11 was
co-immunoprecipitated with COX11-FLAG in the absence of
COX19 (Supplementary Fig. 6A, B). Although the levels of
endogenous COX11 are attenuated in COX19-KO cells, the data
suggest that COX19 is necessary to support COX11 dimerization.
COX11 physically interacts with newly synthesized COX2.
Metabolic labeling of mitochondrial polypeptides in whole cells
with 35S-methionine followed by COX11 immunoprecipitation
(IP) revealed that COX11 exhibits a stable interaction with newly
synthesized COX2 but not with COX1 in WT HEK293T and
143B cells (Fig. 3A and Supplementary Fig. 7A).
The interaction persists in the absence of COX1 (Fig. 3A).
However, it is abolished in the absence of COX20, a factor that
stabilizes COX2 during insertion of its N-proximal transmembrane domain, or COX18, which transiently interacts with COX2
to promote translocation across the inner membrane of the
COX2’s C-tail that harbors the apo-CuA site (Supplementary
Fig. 7B). The lack of COX2 did not promote COX11-COX1
association (Supplementary Fig. 7B). Moreover, COX19 or
PET191 did not stably interact with newly synthesized COX2
(Supplementary Fig. 7A, C). Instead, the three proteins—COX11,
COX19, and PET191—affected the interaction between COX2
and known COX2 folding and CuA metalation chaperones. The
absence of COX11 diminished the interaction of COX2 with
SCO2 by 30% and with COX20 or SCO1 by 80% (Supplementary
Fig. 7D, G). Furthermore, SCO1, COA6, and COX16 failed to
interact with the newly synthesized COX2 in the absence of
PET191 (Supplementary Fig. 7E, G). The absence of COX19
produced similar effects, although 20% of the COA6-COX2
interaction was preserved. By contrast, the interactions of COX11
or SCO2 with COX2 were independent of PET191 or COX19
(Supplementary Fig. 7F–G). These data indicate that SCO2 and
COX11 interact with apo-COX2 before the action of PET191 and
COX19, and prior to the joining of SCO1, COA6, and COX16.
COX1 and COX2 metallochaperones form stable and transient
modules. The steady-state levels of COX19 and COX11 were
interdependent in all contexts tested. Both were depleted in
PET191-KO cells, although COX19 was much more severely
affected (Supplementary Fig. 2B). In contrast, the levels of PET191
were unaltered in the COX19-KO or COX11-KO lines (Fig. 1A, B
and Supplementary Fig. 2A, C). COA6 and SCO2 levels were
attenuated in COX11-KO cells to 50% of WT, and the levels of
COA6, SCO2, SCO1, and COX16 were below 25% in the COX19KO or PET191-KO lines, compared to WT (Fig. 1A, B and Supplementary Fig. 2A, B). Density gradient fractionation and BlueNative (BN)-PAGE analyses of digitonin-extracted native protein
complexes showed that COX11 is part of a ~250 kDa complex
whose integrity depends on COX19 and PET191 (Supplementary
Fig. 8A–D). The three proteins also form several complexes ranging from ~50 to 150 kDa (Supplementary Fig. 8A–D). Next, we
performed IP assays in mitochondrial extracts from WT and each
respective KO cell line reconstituted with a functional FLAGtagged version of the corresponding protein, or candidate protein
interactors relevant to COX1 and COX2 biogenesis—SCO1,
SCO2, COX17, COA6, COX16, and COX10. The results (Fig. 3B,
C and Source Data) indicate that COX11 stably interacts with
COX2, the SCO1/SCO2 CuA metallochaperones, the COX11
chaperone COX19, the heme o synthase COX10, and the putative
COX1 heme a insertase SURF1. These interactions merge the
COX1 and COX2 assembly modules. Moreover, COX17 forms
stable interactions with SCO1/SCO2, and COX10, but not PET191
or COX11. Likewise, COA6 stably interacts with COX2, SCO1/
SCO2, and COX16 (Fig. 3C and Source Data). To speciﬁcally test
6

whether COX19 binds to COX11 in a redox-sensitive manner, as
shown in yeast18, we use mitochondria from cell lines expressing
only COX19-FLAG or COX11-FLAG, prepared extracts in the
presence of 5 mM reduced glutathione (GSH), and performed
reciprocal IP assays. The COX19-COX11 interaction remained
stable (Supplementary Fig. 9).
To examine protein-protein interactions unbiasedly, we analyzed the IPs of COX11, COX19, and PET191 by LC-MS-MS. The
data conﬁrmed the interaction of these three proteins with SCO1,
and the interactions of COX11 with COX19, SCO2, and COX2
(Fig. 3C). The MS studies also indicated potential interactions of
COX11 and PET191 with the heme a synthase COX15, the IMS
CcO assembly factor COA7, and the holo-cytochrome c synthase
HCCS, as the most relevant proteins (Fig. 3C).
To capture transient protein-protein interactions with CcO
metallochaperones occurring during CcO assembly, we used
mitochondria puriﬁed from each respective line treated with the
crosslinker DSP (dithiobis(succinimidyl propionate)) or the
vehicle DMSO. Samples were extracted with 0.4% DDM (ndodecyl β-D-maltoside), incubated with anti-FLAG agarose
beads, and analyzed by immunoblotting to detect 13 candidate
proteins: the 9 bites plus COX2, COX1, COA3, and SURF1. The
original DSP data (see Source Data) is summarized in a
compilation of heatmaps (Fig. 3D) that reﬂect the existence of
several independent complexes with progressively overlapping
compositions. For example, in WT mitochondria, COX11, SCO1,
SCO2, and COX16 co-IP with all the 13 proteins analyzed;
COX10, PET191, and COX17 do not interact with COX1, COX2,
or SURF1; and COX11 and COX19 always co-assemble (Fig. 3D).
PET191 does not co-IP with COX17 or COA6, suggesting it acts
before their incorporation (Fig. 3D). Furthermore, we can
determine the composition of CcO assembly modules by
revealing the effect of the lack of each deleted protein on the
stability and interaction of other factors from the same module
(Fig. 3D). For example, the capacity of COX11 to interact with
COX2 and its chaperones is hindered in the absence of COX19 or
PET191; and PET191 coincides with COX17 in the same complex
only in the absence of COA6 (Fig. 3D). Our data indicate that a
complex containing presumably unmetalated Cu-chaperones and
heme a biosynthetic enzymes assembles and is stabilized by
PET191, which dissociates from the complex before the
association of COX17. COX17 delivers Cu to COX11 and
SCO1/SCO2 before interacting, as a multi-metallochaperone
module, with their target CcO subunits, ﬁrst COX2 and then
COX1. The COX1- and COX2-independent formation of the
metallochaperone module is further supported by demonstrating
that COX11 interactions—particularly with COX19, COX10, and
the SCO1/SCO2 proteins—are preserved in WT cells treated with
chloramphenicol for 72 h to inhibit mitochondrial protein
synthesis, thus preventing any accumulation of COX1/2 (Fig. 3D
and Supplementary Fig. 10C, D). The entrapment of COX10 in
complexes with CuA and CuB chaperones until their Cu-loading
suggests a concerted regulation of metalation of all the redox
centers in CcO. Also, COA3 is detected in the same complexes
that COX10. Both factors are undetectable in complexes
containing the COX2-COX20-COX18 module until the COX1COA3-COX14 module is incorporated. These data suggest a
negative-feedback regulatory loop to coordinate COX1 synthesis
and stabilization with heme a and copper bioavailability.
The redox and Cu-binding state of SCO1 and SCO2 are
modiﬁed by CuA and CuB assembly chaperones. Protein-protein
interaction data predicts that the redox state and Cu binding to
the CuA metallochaperones SCO1 and SCO2 could depend on
CuB assembly chaperones. SCO1 and SCO2 have different roles in
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Fig. 3 CcO subunits and metallochaperones undergo stable and transient interactions to drive and coordinate metal center assembly. A Coimmunoprecipitation (co-IP) of endogenous COX11 with newly synthesized mitochondrial polypeptides, identiﬁed in the right-hand side. The graph shows
the densitometry (average ± SD) of three independent experiments. Black dots represent individual data points. Two-sided unpaired t-test, ****p < 0.0001.
The ratio “α-COX11 IP signal vs. control background signal” for two parameters, COX1/ATP6 and COX2/ATP6, is presented. B Co-IP of COX11-FLAG with
CcO subunits and assembly factors in the presence or absence of the crosslinker DSP. Ex, extract; Un, unbound; IP, immunoprecipitate. C Stable
interactions among CcO assembly factors determined by IP followed by either immunoblotting (WB) or mass spectrometry (MS). D Transient interactions
among CcO assembly factors determined by IP in the presence of the crosslinker DSP (dithiobis(succinimidyl propionate)) or the vehicle DMSO (dimethyl
sulfoxide) followed by immunoblotting. The heat maps show the average quantiﬁcation of three independent experiments. Two-sided unpaired t-test.
*p < 0.05. Figures A, B are representative of three independent repetitions with similar results. Source data for A, B, D are provided as a Source Data ﬁle.
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Fig. 4 SCO1 and SCO2 redox state and copper binding are regulated by COX11, PET191, and COX19. Potential redox and copper (Cu) binding states of
SCO1 (A) or SCO2 (F). B, D, G, I Reverse SCO1 or SCO2 thiol trapping in the indicated cell lines. C, E, H, J The graphs show the quantiﬁcation of six (for
SCO1) or ﬁve (for SCO2) independent experiments as in B, D, G, I, respectively. The bars represent the mean ± SD. Two-sided unpaired t-test,
****p < 0.0001. ns, no signiﬁcant. Figures B, D, G, I are representative of six (B, D) or ﬁve (G, I) independent repetitions with similar results. Source data for
B–D and H–J are provided as a Source Data ﬁle.

CuA assembly11. Cu(I)·COX17 delivers Cu(I) and electrons to
oxidized SCO1, but only Cu(I) to SCO2, which may be reduced
by COA62,14,15,30,31. SCO1 selectively transfers Cu(I) ions to
COX2 based on loop recognition, and SCO2 is a Cu-dependent
thiol reductase of the CuA cysteine ligands in COX232. SCO1 and
SCO2 have two essential cysteines (C169 and C173 in SCO1, and
C133 and C137 in SCO2) arranged in a thioredoxin fold, which
together with a conserved histidine constitute the Cu-binding
residues. SCO2 has an additional cysteine residue, C115, which is
not near the copper coordination center. Each protein can have
the two key cysteines forming a disulﬁde, binding Cu, or reduced
and Cu-free. In reverse thiol trapping assays, the ﬁrst two scenarios would result in the addition of two AMS molecules and
none in the latter scenario (Fig. 4A, F). For SCO1, 75% of the
protein binds 2AMS in WT HEK293T (Fig. 4B, C) or 143B cells
(Fig. 4D, E). The proportion was elevated to 90% in COX16-KO
cells, decreased to 50% in COA6-KO or PET191-KO, and 35% in
8

COX11-KO or COX19-KO while it was restored to 60% in
COX11-KO cells overexpressing PET191 (Fig. 4B, C). No changes
were observed in COX1 or COX2 cybrids (Fig. 4D, E), suggesting
processes independent of these core subunits. The data depicted a
different pattern for SCO2. In WT HEK293T and COX11-KO
cells, 75% of SCO2 bound 2 AMS but increased to 100% in
COX16-KO cells (Fig. 4G, H). The absence of COA6 or PET191
lowered the proportion to 35–40%, and the absence of COX19 to
20% (Fig. 4G, H), suggesting SCO2-COX19 functional cooperation. In WT 143B cells, 90% of SCO2 bound 2 AMS, compared to
65% in the absence of COX1 or COX2 (Fig. 4I, J), which may
reﬂect slower redox recycling of SCO2 in these scenarios.
Mutant PET191(C30A, C41A) accumulate in CcO metallochaperone complexes that dictate the redox state of COX11,
SCO1, and SCO2. PET191 contains six cysteine residues and, as
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predicted by AlphaFold33,34, it is expected to fold in a helical
hairpin analogous to COX17 and other twin CX9C family proteins (Supplemental Fig. 11A). Four cysteines present in the
structural motifs would form two disulﬁdes. The other two, C30A
and C41A, are found within the linker motif and could play roles
beyond structural stabilization. A mutant variant PET191(C30A,
C41A) is stable, partially functional (Supplementary Fig. 4A–C),
and can interact with the same CcO assembly factors as WT
PET191. When expressed in PET191-KO cells, either the WT or
mutant protein interacts with COX11, COX19, COX10, SCO1,
SCO2, COA3, and COX16 (Fig. 3D and Supplementary Fig. 4D).
When expressed in COX11-KO cells, each still interacts with
COX10, SCO1, SCO2, COA3, and COX16 (Supplementary
Fig. 4D), suggesting the existence of an earlier metallochaperone
complex involving these factors (Supplementary Fig. 11B).
However, when expressed in COX11-KO cells, PET191(C30A,
C41A) exerted a dominant-negative effect on CcO levels (Supplementary Fig. 4E–H). This could be due to the mutant protein
partially compromising the mitochondrial import and lowering
the organellar levels of the WT protein (Supplementary Fig. 11B)
and competing with the WT variant for the interaction with other
metallochaperones. Given the pronounced effects of loss of
PET191 on the redox state of the cysteinyl sulfurs of COX11
(Fig. 2B), SCO1 (Fig. 4B), and SCO2 (Fig. 4G), all of which
become more reduced, we tested the redox effects on these three
factors of overexpressing mutant PET191. PET191(C30A, C41A)
overexpression in HEK293T WT cells increased COX11
oxidation, while cells lacking PET191 increased oxidation of
COX11, SCO1, and SCO2 to levels similar to WT (Supplementary
Fig. 11C–E). The restoration of CcO assembly by PET191(C30A,
C41A) is only partial, which could be accounted for by an
increased resistance to be released from the apometallochaperone complex and substituted by COX17.
Coordination of metal center assembly in COX1 minimizes the
transient accumulation of pro-oxidant heme a-COX1 stalled
intermediates. The trapping of COX10 and COX15 in complexes
with CuA and CuB chaperones, until the latter are Cu-charged,
indicates a precise regulation of the metalation of all the redox
centers in CcO to coordinate the process and avoid the accumulation of pro-oxidant intermediates. In yeast and human cells,
endogenous superoxide production, measured with the ﬂuorescent probes DHE and MitoSOX, positively correlates with CcO
activity and cellular respiration, as observed for the COX11-KO,
COX19-KO, and PET191-KO cells (Fig. 5A). However, the levels
of H2O2 detected by the probe H2DCFDA signal were enhanced
in COX19-KO and PET191-KO cells (Fig. 5A). Heme a-Cox1stalled intermediates are potentially cytotoxic to cells as shown in
yeast by the H2O2-sensitivity of sco1Δ and cox11Δ mutants3,35
and, to a lesser extent, in pet191Δ cells (Supplementary Fig. 5D).
The cox11Δ mutation yields an H2O2-sensitivity phenotype
dominant over other CcO mutations, including pet191Δ, which
can be prevented by blocking heme a synthesis by deleting the
PET117 assembly factor (Supplementary Fig. 5D). Similarly, the
human COX19-KO and PET191-KO lines are hypersensitive to
H2O2, a phenotype that can be ablated by COX10 silencing
(Fig. 5B). These data indicate that the H2O2 sensitivity of COX19KO and PET191-KO lines arises from pro-oxidant Cox1 assembly
intermediates involving COX1 and heme a, which underscores
the physiological need for coordination of heme a and Cu centers
assembly during CcO biogenesis.
Mechanistically, the enhanced radical production measured in
the absence of COX19 or PET191 could change the local redox
environment and affect the redox state of the copper metallochaperones COX11, SCO1, or SCO2. However, this is unlikely

ARTICLE

because the metallochaperones become more reduced or do not
bind copper in COX19-KO or PET191-KO cells (0 AMS bound in
the reverse thiol trapping experiments) (Figs. 2B and 4). Silencing
of COX10 in HEK293T cells (Supplementary Fig. 12A, B)
enhances levels of reduced- or apo- forms of COX11 and SCO1
(Supplementary Fig. 12C–E) similar to the absence of COX19 or
PET191 (Figs. 2 and 4). Furthermore, COX10 silencing decreases
the steady-state levels of PET191 and COX19 (Supplementary
Fig. 12A). Altogether, these data along with our IP data (Fig. 3)
indicate that COX10 is necessary for the formation of the early
metallochaperone complexes required to promote the oxidation
or copper metalation of COX11 and SCO1 (Supplementary
Fig. 10B). Consistently, the absence of PET191 did not change the
redox state of COX11 and SCO1 following COX10 silencing
(Supplementary Fig. 12C–E). The redox pattern for SCO2
remained unaltered upon COX10 silencing in HEK293T
WT cells and the mutant backgrounds tested (Supplementary
Fig. 12E), which could indicate that SCO2 enters the assembly
pathway downstream of COX10 release from early metallochaperone complexes or that its redox state is independent of the
formation of these complexes.
Copper binding to SCO1 and SCO2 depends on COX19 or
copper metalation of COX11. To probe the interaction of apoCOX11 with the other metallochaperones, we generated cell lines
expressing non-functional but stable C217D and C219D variants
of COX11 that mimic the SOH state of these residues (Supplementary Fig. 10E–H). Cysteines C217 and C219 form the conserved CFCF motif involved in copper binding28. The point
mutations prevented COX19 accumulation and decreased COX2
levels as in COX11-KO cells, although the residual amounts of
COX2 remained associated with COX11 (Fig. 3D and Supplementary Fig. 10H). Moreover, the FLAG-tagged C219D variant
co-IPed SCO1, SCO2, COX10, and COX1, as did the WT COX11
protein. However, it did co-IP 2-3-fold more of COA6, COX16,
COX17, PET191, COA3, and particularly SURF1, with which it
forms a stable interaction (Fig. 3D and Supplementary Fig. 10H).
These data represent an accumulation of COX1 and COX2
metallochaperone modules stalled in assembly. To assess whether
the metallochaperone complexes formed in the presence of WT
or mutant COX11 contain copper, we extracted them from
puriﬁed mitochondria in native conditions without using crosslinkers, FLAG-immunoprecipitated the complexes, and analyzed
them by inductively coupled plasma MS(ICP-MS) elemental
analysis (Fig. 5C). ICP-MS revealed the presence of signiﬁcant
amounts of Cu in these stable complexes when containing WT
COX11, and the absence of detectable bound Cu in complexes
associated with mutant COX11 (Fig. 5D). Thus, either the presence of mutant apo-COX11 or, most likely, the absence of
COX19, impedes Cu binding by SCO1/SCO2, and probably also
by COX17, which is present in the metallochaperone modules.
Moreover, IP of PET191-FLAG expressed in PET191-KO cells did
not yield any signiﬁcant Cu signal (Fig. 5A). Since PET191 stably
interacts with SCO1, COX16, and COX10 (Fig. 3B), these data
indicate that neither SCO1 nor PET191 bind measurable copper
amounts in these complexes. On the contrary, IP of functional
PET191-FLAG, but not PET191(C30A, C41A)-FLAG, overexpressed in COX11-KO cells, yielded Cu levels 40% of the WT
COX11-FLAG IP (Fig. 5A). Because PET191 never interacts with
COX17 and does not form stable complexes with SCO1 or SCO2
in the absence of COX11 (see Source Data), the results demonstrate that PET191 binds Cu in the absence of COX11, but in the
presence of COX11, PET191 either does not bind Cu or binds it
loosely. Hence, the PET191-driven alternative pathway for CuB
metalation might only operate when the canonical COX11-driven
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pathway is inefﬁcient or overwhelmed, which could occur in
response to stress or in a disease state.
Discussion
This study highlights a set of dynamic protein-protein interactions among CcO-speciﬁc metallochaperones and assembly
10

factors as well as regulatory checkpoints that ensure the coordinated and hierarchical assembly of metal centers in human CcO.
By characterizing cell lines lacking COX11, COX19, or PET191
and the dynamic protein interactome of these proteins, we signiﬁcantly advanced our understanding of the role these proteins
play in CcO biogenesis, identiﬁed CcO metallochaperone complexes, and determined the order in which these proteins interact
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Fig. 5 COX11- and PET191-containing metallochaperone modules coordinate copper and heme center assembly to minimize accumulation of prooxidant deleterious CcO assembly intermediates. A ROS generation in the indicated cell lines measured using superoxide-sensitive dyes dihydroethidium
(DHE) and MitoSOX and the H2O2-sensitive dichlorodihydroﬂuorescein diacetate (CM-H2DCFDA). The bar graphs are quantiﬁcation (mean ± SD) of three
independent experiments. Black dots represent individual data points. Two-sided unpaired t-test, ****p < 0.0001. B H2O2 sensitivity measured as the
release of lactate dehydrogenase (LDH) to the growth medium. In the bottom graph, the inset shows immunoblot analysis of COX10 steady-state levels in
WT and PET191-KO HEK293T cells following 10 days of treatment with siRNA-COX10 or non-targeting (NT) control. ACTIN was used as the loading
control. The bar graphs are quantiﬁcation (mean ± SD) of nine independent experiments. Black dots represent individual data points. Two-sided unpaired ttest, ****p < 0.0001. Black stars are for comparisons with WT, and red starts for comparison with PET191-KO. Immunoblots in this panel are representative
of three independent repetitions with similar results. Source data for the immunoblots are provided as a Source Data ﬁle. C Experimental workﬂow for
copper measurements. Mitochondria isolated from WT or KO cell lines expressing FLAG-tagged COX11 or PET191 were solubilized in native conditions (see
details in the Methods section), then the extracts used for FLAG-immunoprecipitation (IP), the IPed proteins eluted, and analyzed their metal content by
inductively coupled plasma MS (ICP-MS). The panel was created with Biorender.com. D Copper content in COX11- and PET191-containing
metallochaperone modules measured by ICP-MS. Mitochondria were puriﬁed from COX11-KO or PET191-KO cells expressing the indicated FLAG-tagged
proteins. The proteins were immunoprecipitated using anti-FLAG conjugated beads, and their metal content was assessed by ICP-MS. The data is
expressed as total Cu normalized by [34S]. The bar graphs are quantiﬁcation (mean ± SD) of three (COX11-KO + COX11-C219C), six (COX11-KO + COX11
and PET191-KO + PET191 or + PET191-C30A,C41A) or nine (WT, COX11-KO + PET191 or + PET191-C30A,C41A) independent samples. Black dots represent
individual data points. Two-sided unpaired t-test, ****p < 0.0001. Source data for A, B, D are provided as a Source Data ﬁle.

with core subunits COX1 and COX2. Our research also provides
a paradigm to understand how the synthesis, maturation, and
assembly of CcO core subunits are concerted to prevent the
accumulation of cytotoxic pro-oxidant intermediates in
human cells.
This work discloses unanticipated levels of sophistication
surrounding CuB center assembly in human CcO. COX11 is
essential for the assembly of CuB in the aa3-type CcOs of αproteobacteria9,17 and yeast mitochondria16,36,37. Our data indicate that COX11 is also the major CuB insertion factor in human
mitochondria but, contrary to what occurs in yeast, a COX11independent route can contribute up to 15% of assembled and
functional CcO in the absence of COX11. The evolutionary origin
of COX11 has been linked to a need for speciﬁcity to distinguish
the CuB and CuA sites17. In support of this model, many bacterial
heme-Cu oxidases that do not have CuA in addition to CuB do
not require COX11 for CuB assembly, such as R. sphaeroides cbb3type CcO or quinol oxidases9. In these cases, the insertion of CuB
is catalyzed by SCO family proteins17. Unexpectedly, our screen
for suppressors of the partial CuB assembly defect of COX11-KO
cells discarded SCO1 and SCO2 even in the presence of exogenous copper and identiﬁed the twin CX9C protein PET191/
COA5 as a key contributor in human cells.
The data reported herein represent a signiﬁcant step to unveil
the mechanism of action for several elusive twin CX9C proteins in
the mitochondrial IMS. The role of COX17 as a Cu-chaperone
that transfers Cu to SCO1/SCO2 and COX11 is well
established30,38. A physical interaction between COX17 and
SCO1 was previously detected only in a high-throughput afﬁnity
puriﬁcation-MS + Bio-ID study39. Including a crosslinker in our
assays has allowed disclosing the COX17 interactome, which
includes its downstream targets for copper transfer, COX11 and
SCO1/SCO2, but not the CcO core subunits COX1 or COX2. Our
work has identiﬁed PET191 as an apo-metallochaperone complex
stabilizer that interacts with heme a biosynthetic enzymes and
copper chaperones, most prominently with SCO1, and in doing
so, we propose that it acts as the placeholder for COX17.
Moreover, PET191, which contains two cysteines outside its
structural twin CX9C motifs, can also promote CuB assembly in
the absence of COX11, a capacity abolished when the extra
cysteines are mutated. We also report that COX19 plays a role in
stabilizing COX11 and in facilitating COX2 metalation with
SCO2. COX19 contains only the four cysteines in the twin CX9C
motifs and, in yeast, it has been proposed to maintain the reduced
state of this conserved third cysteine in Cox11 by engaging in a
Cox19-Cox11 heterodimer18, which was identiﬁed by deep

learning methods40. Several high-throughput afﬁnity puriﬁcationMS39,41 and deep learning-based structure modeling studies42
anticipated the conservation of the COX19-COX11 complex in
human mitochondria, which we have now demonstrated as part
of an extensive network of interactions discussed below. The
predicted structures of the yeast40 and human42 complexes are
similar and show that COX19 does not make direct contact with
any of the three cysteine residues in COX11. However, we show
that a single point mutation in COX11 residues C217 or C219
does not affect the steady-state level of COX11 but renders the
protein non-functional, which destabilizes its interaction
with COX19.
Studies in yeast suggested that Cox11 could form an intramolecular disulﬁde between the cysteines in the CFCF motif
that is dependent on Cox19 and requires the third Cox11 cysteine
residue18. However, copper binding to COX11 was not taken
into full consideration for data interpretation in this study18.
Also, the COX11-COX19 interaction might have different properties in yeast and human mitochondria since our data indicate
that the COX11-COX19 interaction is redox-insensitive while
the Cox11-Cox19 interaction in yeast is redox-sensitive18. Furthermore, native monomeric COX11 does not form an intramolecular disulﬁde in bacteria and only dimerizes to coordinate
two copper molecules intermolecularly17. We show that in
human mitochondria, the oligomerization of COX11 does not
strictly depend on the protein’s redox or copper-binding states.
COX11 is completely reduced in the absence of COX19 and
several other factors, including PET191, COA6, or COX2, whose
absence severely compromises the stability of COX19. Although
we cannot discard the action of a currently unknown thiol
reductase, we favor a model in which COX19 directly maintains
COX11 in a conformation competent for homodimer copper
coordination.
The yeast Cox11-Cox19 interaction is comparable to the
interaction between the twin Cx9C protein Mdm35 and the lipidbinding protein Ups143,44, which suggests that twin Cx9C proteins could act as stabilizers or folding chaperones to control the
function of speciﬁc IMS proteins18. The human COX11-COX19
and SCO1-PET191 interactions would support this hypothesis.
The CcO assembly model drawn from our data (Fig. 6) proposes
that PET191 is dissociated from SCO1 before it acquires copper
from COX17, and COX19 is dissociated from COX11 before it
delivers copper to COX1. Conformational changes in SCO1 and
COX11 induced by the binding and release of their “speciﬁc” twin
CX9C protein would regulate their functions, as proposed for the
yeast proteins mentioned earlier18. Also, the twin CX9C proteins
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Fig. 6 Model of CcO assembly depicting the coordination of metal center biogenesis. The role of metallochaperone modules and the several regulatory
checkpoints are indicated. See the text for details.

CMC119 and COA631 help stabilize their target proteins, COX1
and SCO2, respectively, making them competent to proceed or
function in the CcO assembly process.
Our results support a concerted maturation of the COX1 and
COX2 metal centers. COX11, COX19, and PET191 proteins have
extensive stable and transient protein interactomes that include
heme a biosynthetic enzymes and CuA and CuB metallochaperones. The data are compatible with recent high-throughput BioID studies in yeast that found Cox15 and Cox11 to localize to
12

mitoribosomal exit tunnel vicinity45, and in human cells wherein,
using SCO1 as a prey, researchers captured COX11, COX19,
COX17, COX16, SCO2, COA6, COX5B-COX6B1, and
COX1539,46. A high-throughput afﬁnity puriﬁcation-MS study
also identiﬁed COX11-COX19-SCO1 physical interactions39.
Furthermore, COX19, which partitions between the cytosol and
the IMS in a copper-dependent manner, was proposed to contribute to transducing a SCO1-dependent mitochondrial redox
signal that regulates cellular copper efﬂux47.
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As depicted in Fig. 6 and Supplementary Fig. 11C, our analyses
demonstrate that PET191 stably interacts with the CuA assembly
factors SCO1-SCO2-COA6 and then recruits the COX11-COX19
pair prior to Cu acquisition. This dual Cu-center assembly
module subsequently undergoes a substitution of PET191 by
COX17, thereby enabling Cu transfer from COX17 to the
downstream metallochaperones. In the mature CcO, most CuA
ligands lie within a region of COX2 that interacts strongly with a
shallow depression on the surface of COX1, such that the
accessibility of CuA to other proteins is minimal. This implies that
chaperone-mediated CuA assembly must occur before COX2
associates with COX1. Concurrently, upon COX17 release, the
metallochaperone module recruits COX2 and assembles CuA
before recruiting COX1 and building CuB. At this stage, COX1
must be hemylated at least in the a site since it is detected in the
COX19-KO and PET191-KO lines. Heme loading into the a and
a3 sites may involve presently unknown heme delivery factors.
However, studies in R. sphaeroides9 and yeast cox11Δ strains3
have shown that the heme a3 moiety can be delivered to this site
in the absence of Cu and that SURF1 plays a relevant role. Our
data indicate that COX19 is released from the maturing CcO
assembly intermediates once COX2 and COX1 have already been
associated. This occurs before COX11 would transfer Cu to
COX1, coinciding with the association of SURF1 to facilitate the
assembly of the heme a3 site. Hence, CuB and the heme a3 moiety
could be incorporated simultaneously into the heterobimetallic
center.
Several regulatory mechanisms have been proposed to facilitate
the formation of the CcO metal centers while minimizing the
formation of reactive assembly intermediates. Different translation regulation mechanisms coordinate COX1 synthesis and
assembly in yeast48 and human cells, wherein COA3 and COX14
interact with nascent COX1 polypeptides49. Heme a biosynthesis
and insertion into yeast Cox1 is regulated by assembly
intermediates50 harboring Cox15 and Shy1, the homolog of
human SURF151. Our data show that human COX11 forms
complexes with COX10 and COX15, as well as COA3 in early
apo-metallochaperone modules until they are Cu-loaded and
competent to metalate COX2 and COX1. In that way, two previously undescribed negative-feedback regulatory loops coordinate COX1 synthesis, CcO metal center formation, and holocomplex assembly, thereby minimizing the accumulation of
deleterious reactive CcO assembly intermediates.
The biomedical relevance of the COX11, COX19, and PET191
protein interactomes is highlighted by mutations in CcO subunits
COX1 and COX2 and the assembly factors PET191, SCO1, SCO2,
COA6, COA3, COX14, COX10, COX15, COX16, COX20, and
SURF1, causing devastating human mitochondrial cardio- and
encephalomyopathies. Therefore, this study may also shed light
on the pathogenic mechanisms underlying these disorders.
Methods
Human cell lines and cell culture conditions. Human HEK293T embryonic
kidney cells (CRL-3216, RRID: CVCL-0063), HEK293 (CRL-1573, RRID: CVCL0045), and 143B osteosarcoma cells (CRL-8303, RRID: CVCL-2270), were obtained
from ATCC. Cybrid cell lines were constructed using enucleated control ﬁbroblasts
and the osteosarcoma 143B TK 206 rho zero cell lines52. COX1 and COX2 mutant
cybrid cells carry a homoplasmic G6930A or G7896A mitochondrial mutation,
respectively, that generates a stop codon and a truncated version of the protein53,54.
The HEK293T COX16 knock-out (KO) cell line55 was provided by Dr. Peter
Rehling (University Medical Center Göttingen, Göttingen, Germany), and the
COA6-KO cell line15 by Dr. Michael Ryan (Monash University, Melbourne, Australia). The HEK293T COX18-KO and COX20-KO cell lines were previously
reported by our group12,56.
Cells were cultured in high-glucose Dulbecco’s modiﬁed Eagle’s medium (DMEM,
Life Technologies) supplemented with 10% fetal bovine serum (FBS), 2 mM Lglutamine, 1 mM sodium pyruvate, 50 μg/ml uridine, and 1x GlutaMax (Thermo
Fisher Scientiﬁc; Waltham, MA) at 37 °C under 5% CO2. Cell lines were routinely
tested for mycoplasma contamination.
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For copper supplementation assays, the complete medium was supplemented
with (i) 1.5 mM Cu-His, (ii) 1 mM CuCl2, or (iii) 1 nM elesclomol (Selleckchem,
STA-4783) + 1 mM CuCl2.
Generation of knockout cell lines and plasmid transfection. To create stable
human PET191-KO lines in HEK293T cells, two gene-speciﬁc pairs of TALEN
constructs were obtained from Thermo-Invitrogen. The pair of left and right
TALENs was designed to target the corresponding exon 1 (Supplementary Fig. 1).
To create stable human COX19-KO and COX11-KO lines in HEK293T cells, we
used CRISPR-CAS9 guide RNAs obtained from OriGene (KN210770 and
KN203238, respectively) designed to bind the exon 1 region of the corresponding
gene (Supplementary Fig. 1).
1.5 × 106 HEK293T cells were transfected with 4 µg of the right and left TALEN
plasmids as a pair with 1 µl of EndoFectin (GeneCopoeia; Rockville, MD) preincubated in 200 µl of OptiMEM-I (Thermo Scientiﬁc). Alternatively,
HEK293T cells were transfected with 2 µg of donor DNA plasmid with puromycin
resistance and gRNA with 1 µl of EndoFectin pre-incubated in 200 µl of OptiMEMI. After 16 h of incubation, media were changed to complete culture medium. Four
consecutive transfections were performed every 3 days. In the case of CRISPRCAS9 transfection, the cells were selected with 2.5 µg/ml puromycin for 3 weeks.
Next, the cells were sorted as single cells in 96-well plates. Single clones were grown
and screened by immunoblotting against PET191, COX11, or COX19 antibodies
(Supplementary Fig. 1), and by genotyping12. For genotyping, the PET191 locus
was sequenced using the oligonucleotides PET191-Forward and PET191-Reverse,
COX11-Forward and COX11-Reverse were used to sequence the COX11 locus and
COX19-Forward and COX19-Reverse were used to sequence the COX19 locus
(Supplementary Table 2 and Supplementary Fig. 1).
The KOs cell lines were reconstituted with C-terminal Myc-DDK-tagged wild-type
version of the corresponding gene and other genes. The human genes PET191, COX19,
COA6, COX17, COX16, and COX10 were obtained in plasmids from OriGene. The
genes COX11, SCO1, and SCO2 were PCR-ampliﬁed from cDNA using primers listed
in the Supplementary Table 2. The Saccharomyces cerevisiae COX11 gene was PCRampliﬁed from genomic DNA using primers listed in the Supplementary Table 2. All
genes were cloned under the control of a truncated Δ5-CMV promoter57 in the Δ5pCMV6-A-Myc-DDK-Hygro plasmid (created from OriGene Technologies; Rockville,
MD; PS100024) using Sfg1 and Mlu1 sites. To generate mutant variants of COX11 and
PET191, we used the Q5® Site-Directed Mutagenesis Kit from NEB. ~10 pg of template
Δ5-pCMV6-A-Myc-DDK-Hygro-COX11 or Δ5-pCMV6-A-Myc-DDK-Hygro-PET191
vector were used, along with the primers COX11_mut_C217A_F, COX11_mut_C217A
_R, COX11_mut_C219A_F, COX11_mut_C219A_R, PET191_mut_C30A_F, PET191_
mut_C30A_R, PET191_mut_C41A_F, PET191_mut_C41A_R (Supplementary
Table 2), designed to include the codon to be mutated. After exponential ampliﬁcation
and the treatment with kinase and ligase, 2.5 µl of the reaction were transformed in
competent Escherichia coli cells. For transfection of all constructs, we used 1 μl of
EndoFectin mixed with 1–2 μg of vector DNA in OptiMEM-I media according to the
manufacturer’s instructions. Media was supplemented with 200 μg/ml of hygromycin
after 24 h and drug selection was maintained for at least 1 month.
For co-overexpression of PET191 and COX17, COX11-KO cells were transfected
with 1 μl of EndoFectin mixed with 1–2 μg of each vector DNA in OptiMEM-I
media according to the manufacturer’s instructions. The cells were selected in
200 μg/ml of hygromycin after 24 h. After 3 weeks of selection, the pool of cells was
sorted as single cells in 96-well plates. Single clones were grown and screened by
immunoblotting against PET191 and COX17 with respective antibodies and clones
expressing both proteins were selected. For co-overexpression of PET191 and
COX17, and one of the SCO genes, SCO1 and SCO2 were cloned into the pCMV6A-BSD plasmid (OriGene Tech., PS100022) using Sfg1 and Mlu1 sites. The selected
clones of co-overexpressing PET191 and COX17 were transfected with 1 μl of
EndoFectin mixed with 1–2 μg of SCO1 or SCO2 expression constructs in
OptiMEM-I media according to the manufacturer’s instructions. The cells were
selected in 50 μg/ml of blasticidin after 24 h and for 3 weeks in total.
siRNA transfection. HEK293T cells or PET191-KO were grown on 6-well plate at
10% conﬂuency and transfected using 5 μl of Lipofectamine RNAiMAX (Thermo
Fisher Scientiﬁc) mixed with either 10 nM of COX10 (GGUGCCAUUUGACUCA
AACtt) siRNA (Ambion‐Life Technologies; Austin, TX); or scrambled control
[BLOCK‐iT Alexa Fluor (Thermo Fisher Scientiﬁc)] in 200 μl OptiMEM-I (Thermo
Scientiﬁc), according to the manufacturer’s speciﬁcations. The cells were silenced for
10 days, and the silencing efﬁciency was conﬁrmed by immunoblotting.
Whole-Cell extracts and mitochondria isolation. For SDS-PAGE electrophoresis,
pelleted cells were solubilized in RIPA buffer (25 mM Tris-HCl pH 7.6, 150 mM
NaCl, 1% NP-40, 1% sodium deoxycholate, and 0.1% SDS) with 1 mM PMSF
(phenylmethylsulfonyl ﬂuoride) and mammalian protease inhibitor cocktail
(Sigma). Whole-cell extracts were cleared by 5 min centrifugation at 20,000 × g
at 4 °C.
Mitochondria-enriched fractions were isolated from at least ten 80% conﬂuent
15-cm plates as described previously12,58,59. Brieﬂy, the cells were resuspended in
ice-cold T-K-Mg buffer (10 mM Tris-HCl, 10 mM KCl, 0.15 mM MgCl2, pH 7.0)
and disrupted with 10 strokes in a homogenizer (Kimble/Kontes, Vineland, NJ).
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Using a 1 M sucrose solution, the homogenate was brought to a ﬁnal concentration
of 0.25 M sucrose, and a postnuclear supernatant was obtained by centrifugation of
the samples twice for 5 min at 1000 × g. Mitochondria were pelleted by
centrifugation for 20 min at 10,000 × g and resuspended in 0.25 M sucrose, 20 mM
Tris-HCl, 40 mM KCl, 10 mM MgCl2, pH 7.4.
Depletion of CcO core subunits. To deplete the cells from mtDNA-encoded
polypeptides, including CcO core subunits, COX1, COX2, and COX3, WT
HEK293T and COX11-KO cells stably expressing COX11-FLAG were treated with
200 µg/ml chloramphenicol for 10 days to inhibit mitochondrial protein synthesis.
As a control, cells were treated with the same volume of the vehicle (100% ethanol).
The medium was changed every 48 h and supplemented with fresh chloramphenicol solution. Mitochondria were isolated as described above.
Denaturing and native electrophoresis, followed by immunoblotting. Protein
concentration was measured by the Lowry method60. 40–80 μg of mitochondrial
protein extract was separated by denaturing SDS-PAGE in the Laemmli buffer
system61. Then, proteins were transferred to nitrocellulose membranes and probed
with speciﬁc primary antibodies against the following proteins: COX11 (dilution
1:1000; OriGene Tech., TA323960), PET191 (dilution 1:500; Sigma; St. Louis, MO;
HPA057768), COX19 (dilution 1:500; Sigma, HPA021226), β-ACTIN (dilution
1:2000; Proteintech; Rosemont, IL; 60008-1-Ig), COX1 (dilution 1:2000; Abcam;
Cambridge, MA; ab14705), COX2 (dilution 1:1000; Abcam, ab110258), COA6
(dilution 1:500; Sigma, HPA028588), COX17 (dilution 1:500; OriGene Tech.,
TA315013), COX16 (dilution 1:1000; Proteintech, 19425-1-AP), COX10 (dilution
1:1000; Sigma, HPA032005), COA3 (dilution 1:1000; Sigma, HPA031966), SCO1
and SCO2 (PRAB4980 and PRAB4982 according to P. Rehling catalog; each at
dilution 1:500; kind gift of P. Rehling who generated, validated, and cited them in
PMID: 2938113655), CMC1 (dilution 1:1000; Sigma, HPA043333), COX5B (dilution 1:1000; Santa Cruz Biotech.; Dallas, TX; sc-374417), SURF1 (dilution 1:1000;
Abcam, Ab155251), CORE2 (dilution 1:2000; Abcam, ab14745), FLAG (dilution
1:1000; Sigma, F3165), COX20 (dilution 1:1000; Sigma, HPA045490), HIGD2A
(dilution 1:1000; Sigma, HPA042715), HA (dilution 1:1000; Thermo Fisher Scientiﬁc, 71-5500), Porin (dilution 1:000; Abcam, ab110326). Horseradish
peroxidase-conjugated anti-mouse or anti-rabbit IgGs were used as secondary
antibodies (dilution 1:10,000; Rockland; Limerick, PA). β-ACTIN was used as a
loading control. Signals were detected by chemiluminescence incubation and
exposure to X-ray ﬁlm. Optical densities of the immunoreactive bands were
measured using the ImageLab (Biorad; Hercules, CA) software or the ImageJ
software version 1.53r in digitalized images.
Blue-Native polyacrylamide gel electrophoresis (BN-PAGE) analysis of
mitochondrial respiratory chain complexes, supercomplexes, and CIV assembly
intermediates in native conditions was performed as described previously62,63. To
extract mitochondrial proteins in native conditions, we pelleted and solubilized
mitochondria in 100 μl buffer containing 1.5 M aminocaproic acid and 50 mM BisTris (pH 7.0). After optimizing solubilization conditions, we used digitonin at the
optimal 1:2 (digitonin: protein) proportion. Solubilized samples were incubated on
ice for 15 min and pelleted at 20,000 × g for 30 min at 4 °C. The supernatant was
supplemented with 10 µl of sample buffer 10X (750 mM aminocaproic acid, 50 mM
Bis-Tris, 0.5 mM EDTA (ethylenediaminetetraacetic acid), 5% Serva Blue G-250).
Native PAGE™ Novex® 3–12% Bis-Tris Protein Gels (Thermo Fisher) gels were
loaded with 60–100 μg of mitochondrial protein or total cell extracts. After
electrophoresis, proteins were transferred to PVDF membranes using an eBlot L1
protein transfer system (GenScript, Piscataway, NJ) and used for immunoblotting.
Characterization of the MRC and oxidative phosphorylation system. The
enzymatic activity of mitochondrial respiratory chain Complex IV (cytochrome c
oxidase, CcO) was assessed spectrophotometrically using frozen-thawed cells by
following the oxidation of exogenous reduced cytochrome c as reported64. Values
were normalized by total protein concentration measured by the Lowry method60.
Endogenous cell respiration was measured polarographically at 37 °C using a
Clark-type electrode from Hansatech Instruments (Norfolk, United Kingdom). Cell
respiration was assayed in cultured cells as reported64. Brieﬂy, trypsinized cells
were washed with respiration buffer (RB) containing 0.3 M mannitol, 10 mM KCl,
5 mM MgCl2, 0.5 mM EDTA, 0.5 mM EGTA, 1 mg/ml BSA and 10 mM KH3PO4
(pH 7.4), and resuspended at ~2 × 106 cells/ml in 0.5 ml of the same buffer, airequilibrated at 37 °C. The cell suspension was immediately placed into the
polarographic chamber to measure endogenous cell respiration. The speciﬁcity of
the assay was determined by inhibition of complex IV activity and then respiration,
with 0.8 µM KCN. Values were normalized by total cell number.
To obtain total mitochondrial cytochrome spectra, we extracted cytochromes
from 8 mg of WT or respective KO mitochondria by resuspending them in 1190 μl
of water with 70 mg of KCl (to 670 mM concentration), then adding a buffer
containing 50 mM Tris, pH 7.5, and 1% potassium deoxycholate in a ﬁnal volume
to 1.4 ml, and gently mixing by pipetting. The extracts were cleared by
centrifugation at 21,000 × g for 20 min at 4 °C. Sodium cholate was added to the
clear supernatant to a 1% ﬁnal concentration. Half of the solution was reduced with
sodium dithionite, while the other half was oxidized with potassium ferricyanide,
and the difference spectra of the reduced versus oxidized extracts between 500 to
14

650 nm were recorded at room temperature using a UV-2401PC Shimadzu
spectrophotometer. The wild-type α absorption bands corresponding to
cytochromes a and a3 have maxima at 603 nm; the maxima for cytochrome b and
for cytochrome c and c1 are 560 and 550 nm, respectively. The heights of the peaks
and the area under the peaks in three independent experiments were calculated
using the of the Quant mode of the UV-Probe software (Shimadzu) and expressed
as the a + a3/b ratio. Similar values were obtained when using the peaks’ height and
the area under the peaks.
Pulse labeling of mitochondrial translation products. Mitochondrial protein
synthesis was determined by pulse-labeling 70–80%-conﬂuent 15 cm plates of
HEK293T, KO cell lines, 143B, or cybrid cell lines. The cell cultures were incubated
for 30 min in DMEM without methionine and then supplemented with 100 µl/ml
emetine to inhibit cytoplasmic protein synthesis as described12. Cells were labeled
for 30 min (Pulse) at 37 °C with 100 μCi/ml [35S] methionine (PerkinElmer Life
Sciences, Boston, MA). After incubation, the cells were washed once with 1X PBS,
collected by trypsinization, and whole-cell extracts were prepared by solubilization
in RIPA buffer (1% NP-40, 0.1% SDS, 0.5% Na-deoxycholate, 150 mM NaCl, 2 mM
EDTA, and 50 mM Tris-HCl, pH 8.0) supplemented with 1 mM PMSF, and 1X
EDTA-free mammalian protease inhibitor cocktail (Roche # 11836170001). After
incubation, the cells were washed, trypsinized, collected, and proteins were
extracted. 100 μg of each sample was separated by SDS-PAGE on a 17.5% polyacrylamide gel, transferred to a nitrocellulose membrane and exposed to Kodak
X-OMAT X-ray ﬁlm. The membranes were then probed with a primary antibody
against β-ACTIN as a loading control.
For immunoprecipitation assays, pelleted cells were extracted in 800 µl of PBS,
0.4% n-dodecyl-β-D-maltoside (DDM), 1 mM PMSF, and 8 µl of protease inhibitor
cocktail (Sigma, P8340) for 10 min on ice. After centrifugation at 20,000 × g for
30 min at 4 °C, the extract (Ex) was incubated overnight with 25 µl of protein A
agarose beads with rabbit IgG (negative control) or speciﬁc antibody raised in
rabbit. The unbound material (Un) was removed, and the beads were washed ﬁve
times in 1 ml PBS with 0.05% DDM. Then, the beads were incubated at 37 °C for
1 h in 60 µl of Laemmli buffer 2 x to release bound material (IP). Equivalent
amounts of all fractions were separated by SDS-PAGE using a 17.5%
polyacrylamide gel. Gels were transferred to a nitrocellulose membrane and
exposed to X-ray ﬁlm.
Immunoprecipitation. For immunoprecipitation of FLAG-tagged proteins, 1 mg of
mitochondria of KOs with FLAG-tagged or wild-type HEK293T (as negative
control) were incubated in 1 mM DSP (dithiobis[succinimidylpropionate], Thermo
Scientiﬁc) or in DMSO carrier control for 1.5 h at 4 °C. DSP is thiol-cleavable,
primary amine-reactive with an 8-carbon spacer arm crosslinker. The reaction was
stopped by incubation with 10 mM Tris-HCl solution, pH ~7.4. After spin, the
mitochondria were extracted in 600 µl of PBS, 0.4% DDM, 1 mM PMSF, and 8 µl of
protease inhibitor cocktail (Sigma, P8340) for 10 min on ice. After centrifugation at
20,000 × g for 30 min at 4 °C, the extract (Ex) was incubated for 4 h at 4 °C with
25 µl of beads conjugated with a FLAG antibody (anti-DYDDDDDK beads,
Sigma), previously washed in PBS. The unbound material (Un) was removed, and
the beads were washed ﬁve times in 1 ml of PBS 0.05% DDM. Then, beads were
incubated for 30 min in 65 °C with 100 µl of Laemmli buffer 2 x to release bound
material (IP). Equivalent amounts of all fractions were analyzed by SDS-PAGE and
immunoblotting.
To test the redox-sensitivity of the COX11-COX19 interaction, 1 mg of
mitochondria were pre-incubated in the presence of 5 mM GSH or left untreated
for 15 min at 4 °C. Following two washes with PBS, treated and non-treated
mitochondria were used for extraction with 0.4% DDM and immunoprecipitation
assays as described earlier.
Immunoprecipitation and LC-MS-MS analysis. For LC-MS-MS analysis, the
samples were immunoprecipitated as described above. The bound material was
extracted from the beads by incubation with a 62.5 mM Tris-HCl pH 6.5 and 2%
SDS solution. The extracted proteins were precipitated using 100% ice-cold acetone
overnight at −20 °C to remove residual detergent. The next day, the samples were
centrifuged at 20,000 × g for 15 min at 4 °C. The pellet was washed with 100% icecold acetone. The ﬁnal pellet was air-dried and analyzed by LC-MS/MS using the
services of the Keck Biotechnology Proteomics center at Yale University, and
the SPARC BioCentre (Molecular Analysis) at The Hospital for Sick Children
in Toronto (Canada). Data was visualized using the proteome software Scaffold v 5.
Thiol trapping analyses of COX11, SCO1, and SCO2. We used a reverse thiol
trapping assay to analyze the in organello redox state of cysteines in COX11, SCO1,
and SCO2 state of cysteines, as described previously65. Brieﬂy, 100 µg of mitochondria puriﬁed from WT or KO cell lines were ﬁrst incubated for 30 min under
isotonic conditions with 80 mM of membrane-permeable iodoacetamide (IAA), a
compound that covalently binds free thiols. After incubation, the samples were
washed twice with 1 ml of PBS to remove unbound IAA. Mitochondria were then
resuspended in 60 µl of PBS and solubilized in the presence of 0.2% SDS. Next, to
reduce all the native oxidized cysteines (not bound by IAA), 5 mM of the reducing
agent TCEP (tris(2-carboxyethyl)phosphine) was added to the samples that were
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incubated for 12 min at 95 °C and let to cool down. The cysteines that IAA had not
blocked were subsequently identiﬁed by incubation for 1 h at room temperature in
the dark with 4.5 mM AMS (4-acetamido-4′-maleimidylstilbene-2,2′-disulfonic
acid), a compound that binds free thiols, adding ~0.5 kDa for every molecule
bound. Complete reduction of COX11, SCO1 or SCO2 was tested by reducing the
proteins ﬁrst with TCEP, and then adding excess IAA, followed by AMS addition.
The maximum shift of reduced COX11, SCO1, or SCO2 was determined by
reducing the sample with TCEP during extraction, quickly followed by treatment
with AMS. Finally, the samples were supplemented with non-reducing Laemmli
sample buffer and analyzed by non-reducing SDS-PAGE (12% for COX11 or 10%
for SCO1 and SCO2) followed by immunoblotting.
Sucrose gradient sedimentation analysis. Sucrose gradient sedimentation analyses were performed as described previously66. One mg of WT or respective KO
mitochondria were extracted in 300 µl of 20 mM Tris pH 7.5, 50 mM KCl, 1%
digitonin, 1 mM PMSF, and 1 x protease inhibitor cocktail. The lysate was spun at
20,000 × g for 30 min at 4 °C, and the clariﬁed extract was loaded onto a 5 ml
7–20% sucrose gradient containing 20 mM Tris pH 7.5, 50 mM KCl, 0.1% digitonin, and 1 mM PMSF buffer and centrifuged at 150,000 × g for 15 h at 4 °C. The
gradients were fractionated into 13 fractions, TCA-precipitated and the pellets
resuspended in Laemmli buffer and analyzed by immunoblotting.
Copper measurements. Determination of copper in COX11- or PET191containing metallochaperone modules was performed by using immunoprecipitates of these proteins and inductively coupled plasma mass spectrometry (ICPMS). For sample preparation, we used 16 mg of mitochondria puriﬁed from the
following cell lines: HEK293T WT or COX11-KO cells stably expressing WT or
cysteine mutant versions of COX11-FLAG, COX11-KO cells stably expressing
PET191-FLAG, and PET191-KO cells stably expressing PET191-FLAG. Mitochondria were solubilized in 0.4% DDM to extract COX11 or PET191 in native
conditions, as described earlier. Then, we performed a large-scale immunoprecipitation assay using anti-FLAG-conjugated sepharose beads, and the metals were
extracted from the immunoprecipitate by protein denaturation with 1% SDS. The
samples were lyophilized, incubated overnight with 100 μl of nitric acid at 65 °C,
diluted 20-fold, and metals in the samples were measured using ICP-MS as
described previously67. Brieﬂy, the samples were digested in 100 μl of 70% w/v trace
metal-grade nitric acid for 14 h at 65 °C. The digests were cooled down to room
temperature, centrifuged, and diluted 20-fold into the autosampler of the ICP-MS,
with a 2% nitric acid spiked with 50 μg/L Gallium as internal standard (ﬁnal
concentration). The instrument consists of an Agilent 7500cx (Santa Clara, CA)
operating in Mix reaction mode (3.5 ml H2 and 1.5 ml He per min) to remove
polyatomic interferences in the collision cell. The samples were loaded using an
autosampler (ESI, Omaha, NE) using a 6-port injection valve with a 125 μl sample
loop. The samples were injected at a ﬂow rate of 55 μl/min with the following
operating conditions for the ICP-MS: Ar carrier ﬂow, 1.0 L/min; Ar make-up ﬂow,
0.1–0.2 L/min; forward power, 1,500 W; Ar plasma gas, 15 L/min, Ar auxiliary gas,
1 L/min. Concentrations were calculated using an external calibration curve, with
50 ppb Ga as the internal standard. All solutions for metal analysis used metalgrade water and nitric acid. For comparisons among samples from different cell
lines, the total Cu concentration data was normalized by [34S] and expressed as Cu/
S ratio.
Oxidative-stress measurements. Reactive oxygen species (ROS) measurements
were performed by ﬂow cytometry, using three different dyes, DHE (2.5 mM) and
MitoSOX (2 mM) to preferentially detect superoxide anion, and CM-H2DCFDA
(5 mM) to preferentially detect hydrogen peroxide. Cells were grown in a 6-well
plate and incubated with the dye for 30 min. Then, the cells were washed in PBS,
resuspended in Hanks solution, and analyzed using a BD LSR II ﬂow cytometer.
We used cells treated for 1 h at 37 °C with 100 μM H2O2 or 1 μM antimycin A as a
positive control
Cytotoxicity assay. The cell sensitivity to oxidative stress was assessed colorimetrically with the Cytotoxicity Detection LDH Kit (Sigma, 11644793001). WT
and KOs cells were grown to 80% conﬂuency in 6-well plates. Following aspiration
of the medium, the cultures were carefully washed with PBS and incubated in FBSfree medium supplemented with 0, 300 or 500 μM H2O2 for 7 h. One hundred μl of
medium was used per assay. LDH activity was measured according to the manufacturer’s instructions.
Yeast strains and growth conditions. Yeast strains used in this work were of the
W303 genetic background (Supplementary Table 3). The cox11Δ, pet191Δ,
pet117Δ, coa3Δ, cox11Δcoa3Δ, cox11Δpet191Δ, and cox11Δpet117Δ strains were
generated in vivo using homologous recombination of PCR-ampliﬁed gene-speciﬁc
knock-out cassettes containing HIS3, URA3MX, or KanMX4 selection markers
ﬂanked by DNA sequences with homology to the upstream and downstream
chromosomal regions of the coding sequence for the deleted gene. The plasmid for
wild-type Pet191-6xHIS (containing the hexa-His epitope) expression was
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generated by PCR ampliﬁcation of PET191 from genomic DNA followed by
restriction enzyme cloning into the pRS426 vector containing the MET25 promoter
and CYC1 terminator. Depending on the experiment, yeast cells were cultured in
yeast extract-peptone (YP) or synthetic complete (SC) media lacking nutrients
(amino acids or nucleotides) necessary to maintain plasmid selective pressure68
containing either 2% glucose, 2% galactose, or 2% glycerol/2% lactic acid mix as the
carbon source. Growth tests to assess respiratory capacity and quantify hydrogen
peroxide sensitivity were carried out as before69,70. Cultures used for growth tests
were grown overnight in SC media lacking relevant nutrients to maintain plasmid
selection, then normalized to OD600 of 1 and spotted onto SC plates with or
without 1 mM CuSO4.
For yeast/human COX11 heterologous complementary studies, yeast strains
were grown in the following standard culture media: YPD (2% glucose, 1% yeast
extract, 2% peptone), YPEG (2% ethanol, 3% glycerol, 1% yeast extract, 2%
peptone) and SC-EG (2% ethanol, 3% glycerol, 0.67% yeast nitrogen base without
amino acids) as described71. Strains grown in liquid and solid media were
incubated at 30 °C. The ScCOX11 gene was ampliﬁed from genomic DNA and
cloned into pGML3 plasmid using restriction sites BamH1 and HindIII. The
HsCOX11 gene was ampliﬁed from COX11 cloned in pCMV6 plasmid (OriGene)
and sub-cloned into pGML4 plasmid using restriction sites Kpn1 and Sal1. The
primers used are listed in the Supplementary Table 2. The yeast strain cox11Δ was
reconstituted either with yeast ScCOX11 in pGML3 (LEU resistance and fused to a
C-terminal hemagglutinin HA-tag) or human HsCOX11 in pGML4 (URA
resistance). Mitochondria were puriﬁed from yeast cultures grown in liquid YPGal
media (2% galactose, 1% yeast extract, 2% peptone) to mid-exponential phase as
described72.
Assays in Saccharomyces cerevisiae. To assess hydrogen peroxide sensitivity of
yeast cells of interest, cells we cultured to mid-log phase, normalized, and acutely
treated with 1 mM H2O2 for 1 h at 28 °C. Following treatment, cultures were
diluted to 300 cells per sample and plated to assess viable colony forming units
after 48 h of growth at 28 °C. Cells were examined in 7 biological replicates, and
obtained experimental values were statistically analyzed by one-way ANOVA and
Student’s t-test.
For immunoblot analysis of yeast mitochondria, mitochondria-enriched
fractions were isolated using established protocols73. Mitochondrial proteins were
separated by SDS-PAGE and transferred to nitrocellulose membrane, blocked in
5% non-fat milk in PBS with 0.1% Tween-20, and incubated with relevant primary
antibodies and goat anti-mouse or goat anti-rabbit horseradish peroxidase-coupled
secondary antibodies (Santa Cruz Biotechnology) at dilutions 1:10,000. Proteins of
interest were visualized by incubation of said membranes with chemiluminescence
reagents (Thermo Scientiﬁc) and exposure to X-ray ﬁlm. The following primary
antibodies were used: mouse anti-porin (Dilution 1:1000; Thermo Scientiﬁc
459500) and rabbit anti-Pet191 (dilution 1:500; kindly provided by Dr. Agnieszka
Chacinska, IMol Institute, Warsaw, Poland; Ab reported in ref. 74). For yeast/
human COX11 heterologous complementary studies, mitochondria isolated from
cox11Δ yeast strains expressing yeast or human COX11, were resuspended in
Laemmli buffer and analyzed by immunoblotting using antibodies again HA
(dilution 1:1000; Invitrogen 71-5500), chicken anti-yeast Cox11 (dilution 1:5000;
gift from Dennis Winge (University of Utah) reported in ref. 36), and rabbit antihuman COX11 (OriGene, TA323960). All antibodies were tested for reliability to
ensure speciﬁcity of detection.
Statistical analysis. Unless indicated otherwise, all experiments were performed at
least in biological triplicates and results were presented as mean ± standard
deviation (SD) or standard error of the mean (SEM) of absolute values or percentages of control. For treatments with copper or elesclomol, for each cell line, the
multiple plates used where randomly selected without applying any particular
method, for treatment or no treatment. Statistical p values for comparison of two
groups were obtained by applying a Student’s two-tailed unpaired t-test. For
comparison of multiple groups, performed one-way analysis of variance (ANOVA)
followed by Tukey’s post-hoc test for all the groups, using the GraphPad Prism
9.3.1. A p < 0.05 was considered signiﬁcant test. Exact p values are indicated in the
graphs, except for p < 0.0001 that are denoted as ****. Data in X-ray ﬁlms were
digitalized and analyzed with the ImageJ software version 1.53r or the histogram
panel of Adobe Photoshop.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.

Data availability
All unique/stable reagents generated in this study (plasmids and cell lines) are available from
the corresponding author with a completed Materials Transfer Agreement. Proteomics data
have been deposited in PRIDE75 as PXD034576, PXD034578, PXD034579, and PXD034577.
The ICP-MS data has been uploaded to Mendeley data: Nyvltova, Eva (2022), “Nyvltova
et al. ICP-MS Data”, Mendeley Data, V1, doi: 10.17632/w2yk8g568t.1 and can be accessed at
https://data.mendeley.com/datasets/w2yk8g568t/1. Source data are provided with this paper.
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